dEEGtal Insight

Private

GenevaHealthcare & Life Scienceshttps://www.deegtal.ai/

Last Round

Grant

Sep 23, 2025

Total Funding Raised

$1.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

dEEGtal Insight is a medical technology company that provides AI-powered software to enhance and accelerate the diagnosis of epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Devices, Precision Medicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

epilepsy diagnosisEEG analysisAI diagnosticsmedical AIepilepsy risk scoremedtechdiagnostic softwareclinical decision supportelectroencephalogram analysisEEGneurology softwareautomated EEG interpretationclinical workflow integrationprecision medicinedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

dEEGtal Insight Comps

Public and private peers based on sector, stage, and business model.

dEEGtal Insight comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

dEEGtal Insight Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 23, 2025
Seed	Dec 13, 2024
Grant	Aug 26, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Eric Ménétré

CEO & Co-Founder

Founding Team

dEEGtal Insight Investors

Notable investors and investment history

dEEGtal Insight investors
Investor	Rounds
Wyss Center for Bio and Neuroengineering	Seed
Innosuisse	Grant
Venture Kick	Grant, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 23, 2025
$704K grant received from Innosuisse.
Dec 13, 2024
$1.1M round led by Wyss Center for Bio and Neuroengineering

View all signals

dEEGtal Insight Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

dEEGtal Insight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about dEEGtal Insight's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva

Employee Range6

Year Founded2024

Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.